Deciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention

Background. A long-acting injectable formulation of rilpivirine (RPV), under investigation as antiretroviral pre-exposure prophylaxis (PrEP), may facilitate PrEP adherence. In contrast, cross-resistance between RPV and nonnucleoside reverse-transcriptase inhibitors comprising first-line antiretrovir...

Descripción completa

Detalles Bibliográficos
Autores principales: Glaubius, Robert L., Parikh, Urvi M., Hood, Greg, Penrose, Kerri J., Bendavid, Eran, Mellors, John W., Abbas, Ume L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047428/
https://www.ncbi.nlm.nih.gov/pubmed/27703992
http://dx.doi.org/10.1093/ofid/ofw125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047428/
https://www.ncbi.nlm.nih.gov/pubmed/27703992
http://dx.doi.org/10.1093/ofid/ofw125

Ejemplares similares